Treatment of Hodgkin's disease.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D003510:Cyclohexanes / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D009607:Nitrosourea Compounds / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003510:Cyclohexanes; D009607:Nitrosourea Compounds; D002330:Carmustine